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ABSTRAK 
PENGENALAN: 
Jaundis menrupakan masalah yang biasa dihadapi oleh bayi di awal usia kelahiran. 
Pemantauan bagi masalah ini adalah penting untuk mengelakkan berlakunya 
komplikasi. Bilispect merupakan satu alat yang boleh memberi bacaan jaundis melalui 
kulit. Alat ini boleh membantu pengurangan sampel darah untuk bayi. 
OBJEKTIF: 
Untuk menilai kebolehpercayaan Bilispect sebagai alat untuk mengukur tahap jaundis 
bayi, sebelum dan selepas rawatan ‘phototherapy’. 
KAEDAH: 
Kajian ini merupakan kajian ‘cross sectional’ di HUSM untuk bayi yang mengalami 
masalah jaundis dan memenuhi kriteria yang ditetapkan. 
KEPUTUSAN: 
Sejumlah 74 bayi telah menyertai kajian ini. Seramai 44 bayi menyertai kedua-dua 
bahagian, sebelum ‘phototherapy’ dan selepas ‘phototherapy’. Penambahan seramai 15 
orang bayi samada untuk bacaan sebelum ‘phototherapy’ atau selepas ‘phototherapy’. 
Ini menjadikan 59 sampel untuk kedua-dua bahagian. Keputusan menunjukkan tiada 
perbezaan dalam distribusi jantina di kedua-dua bahagian. Purata umur adalah 
lingkungan 3 hari selepas kelahiran dan purata usia kandungan ialah 39 minggu. 
Perbezaan bacaan keputusan di antara dua kaedah bagi sebelum ‘phototherapy’ ialah -
132.6 ke 190.8. Manakala bagi keputusan selepas ‘phototherapy’ ialah -45.2 ke 164.0. 
Penilaian Pearson correlation ialah lemah iaitu nilai r 0.466 dan pertengahan iaitu nilai r 
x 
 
0.566 bagi kumpulan sebelum dan selepas ‘phototherapy’. Peratusan persamaan di 
antara kumpulan ujian darah bilirubin dan bacaan Bilispect ialah tinggi dengan nilai 
93.22% bagi sampel pre-‘phototherapy’ dan 96.6% bagi sampel pasca-‘phototherapy’. 
 
 KESIMPULAN: 
Keputusan menunjukkan bacaan Bilispect berkadaran dengan ujian darah bilirubin dari 
segi statistik namun berikutan terlalu banyak sampel yang mempunyai perbezaan yang 
besar, penggunaan Bilispect dalam klinikal adalah terbatas. 
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ABSTRACT 
 
INTRODUCTION : 
Neonatal jaundice commonly occurred in newborn babies. The monitoring of it 
becomes very important to prevent complications. Blood taking is an invasive 
procedure that associated with pain in newborn. Availability of new devices with 
updated technology leading to non invasive monitoring in newborn. Development 
of Bilispect as transcutaneous bilirubinometer gave opportunities to reduce blood 
taking in newborn.   
OBJECTIVES: 
To test reliability of Bilispect in monitoring bilirubin level of term babies, pre and 
post-phototherapy.  
METHODS: 
This study was a cross sectional study in HUSM for term babies with neonatal 
jaundice who fulfilled inclusion criteria.   
RESULT: 
There were total of 74 babies involved in this study. Among these, 44 babies 
involved in both part pre-phototherapy and post-phototherapy reading. Additional 
of 15 babies only involved in one part of the study, either pre-phototherapy or 
post-phototherapy. Total of 59 samples were collected in each part. The gender 
distribution was equal for pre and post-phototherapy group. The mean age was 3.9 
days with mean gestation was 39weeks. The differences of serum bilirubin and 
Bilispect reading for pre-phototherapy result was from -132.6 to 190.8. For the 
post-phototherapy result, the differences value range from -45.2 to 164.0. Pearson 
xii 
 
correlation value derived were weak positive correlation (0.466) and moderate 
positive correlation (0.566) for pre and post-phototherapy respectively. The Bland 
Altman plot degree of agreement between these methods were 93.22% for pre-
phototherapy and 96.6% for post-phototherapy. 
CONCLUSION: 
The results of this study showed that the Bilispect device had a statistically 
significant correlation with the serum bilirubin values. However for too many 
samples the differences between the two were too big to support clinical usage of 
the Bilispect at this point in time. In conclusion serum bilirubin is still a gold 
standard for jaundice monitoring in newborn. 
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CHAPTER 1: INTRODUCTION 
 
 
1.1 History of the jaundice  
The word jaundice comes from the root ‘jeune’, which means yellow in French. The yellow 
color resulted from the unconjugated, non-polar, lipid soluble bilirubin pigment in the skin. 
Neonatal jaundice is a common problem. Up to 60% of term babies have jaundice and it is more 
common in premature babies; around 80%. 
 Even though neonatal jaundice is in most case benign and self-limiting (William Cashore; 
2010), in babies with severe jaundice, the unconjugated bilirubin enters the brain and is 
neurotoxic. That is why managing neonatal jaundice is very important as early treatment can 
avoid the progression to severe jaundice. There are several risk factors that can put the baby at 
higher risk to develop jaundice. By recognizing the risk factors, earlier treatment can be started 
and the unwanted outcomes from severe jaundice can be avoided.  
 Mild jaundice is part of a physiological process in newborn babies (Blackburn, 1995). A 
normal transition in the bilirubin metabolism leads to this problem. In utero, the placenta is the 
place where bilirubin is excreted for the baby. After the delivery mainly the liver is responsible 
for the metabolism and excretion of bilirubin.  Due to immaturity of the liver in newborns, 
accumulation of bilirubin occurs. The high number of red blood cells in newborn and the shorter 
life span of the individual red blood cell carrying foetal haemoglobin also contribute to this 
problem. In premature babies, the organs are more immature compared to term babies and the 
incidence of haemolysis is higher, which explains the higher jaundice incidence in premature.  
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1.2 Risk factors for neonatal jaundice 
Prematurity is one of the risk factors for neonatal jaundice and sometimes can lead to 
early onset and severe jaundice. Thus, knowing the correct gestational age for the babies is vital 
as we might miss early detection of severe jaundice in premature babies. ABO incompatibility 
and Rhesus incompatibility are also risk factors for neonatal jaundice (William, 2010). It was 
made compulsory for pregnant ladies to do the blood group and rhesus investigation upon 
booking. In a way, the health staff should be more alert looking for jaundice in babies of a rhesus 
negative mother or O blood group mother. As we practice in HUSM, a baby of a rhesus negative 
mother must be admitted straight away at birth for monitoring of early onset jaundice. The 
jaundice work up is taken at birth.  
There is higher incidence of jaundice in breastfed babies compared to formula-fed babies 
(Brown LP et al, 1993). However the recommendation is to continue breastfeeding. This is 
because; breastfeeding alone will not lead to severe jaundice. Another important risk factor for 
jaundice is G6PD deficiency and neonatal sepsis. In Malaysia, the screening program is 
compulsory for G6PD deficiency in all newborn babies using the cord blood. As in HUSM, 
postnatal ward nurses will trace the result and inform the respective health care teams and the 
mother. The baby will be admitted for observation and, if jaundice occurrs, early treatment, till 
day 5 of life. Further education on G6PD deficiency will be given to parents. Neonatal sepsis 
needs to be recognized and treated early. Delay in treating neonatal sepsis will impair the 
bilirubin metabolism and leads to severe jaundice. Risk factors for jaundice are listed in table 1. 
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Table 1: Risk factors/causes for neonatal jaundice. 
Risk factor for jaundice Common risk factors 
• Prematurity 
• ABO and Rhesus 
incompatibility 
• G6PD deficiency 
• Cephalohematoma or 
bruises 
• Exclusive breastfeeding 
• Sepsis 
• Polycythemia  
• Hypothyroidism 
• Gilbert Syndrome  
 Less common risk 
factors/causes 
• Crigler-Najjar syndrome, 
type II and II 
• Galactosemia 
• Tyrosinemia 
• Hypermethionemia 
• Hypopituitarism 
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1.3 Pathogenesis of jaundice 
Bilirubin is a product of hemoglobin breakdown. It is produced in the 
reticuloendothelial system. Hemoglobin will break into heme and globin. Globin will 
be recycled. Heme will be transformed to biliverdin by the action of heme 
oxygenase. Next, water soluble biliverdin is reduced to unconjugated bilirubin. 
Because of the hydrophobic nature, unconjugated bilirubin is transported in the 
plasma tightly bound to albumin. A minute fraction of unconjugated bilirubin is not 
bound to albumin, and it is this fraction that has the potential to cross the blood brain 
barrier, leading to the complication of neurotoxicity.  When bilirubin reaches the 
liver, it is transported into the liver cell and it binds to ligandin. Uptake of bilirubin 
into the hepatocytes is increased with the increment of ligandin concentration. 
Phenobarbitone can increase ligandin concentration.  Bilirubin is bound to 
glucuronic acid (conjugated) in the hepatocytic endoplasmic reticulum in a reaction 
catalyzed by uridine diphosphoglucuronyltransferase (UDPGT). Monoconjugates are 
formed first and predominate in the newborn. Diconjugates appear to be formed at 
the cell membrane and may require the presence of the UDPGT tetramer.  After 
being converted to a water soluble molecule, bilirubin is excreted in the bile and 
reaches the intestines. In the intestines, about 20% will be reabsorbed to the 
enterohepatic circulation after being converted back to unconjugated by the beta 
glucoronidase enzyme. The rest will be excreted via urine as urobilinogen or in the 
feces as stercobilinogen.  
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1.4 Monitoring of jaundice 
The most non-invasive method of monitoring jaundice is by clinical observation and 
estimation. Jaundice is visible when the bilirubin level is around 86-120umol/L (Malaysia 
CPG –Neonatal jaundice 2014). This method is referring to Kramer’s rule as a guideline 
(Kramer Ll, 1969) (Figure 1). The body area is divided into 5 categories. The severity of 
jaundice is increasing in trend from area 1 to area 5.    
It is very important to train the primary healthcare staff to detect the jaundice in newborn 
babies. According to Kramer’s rule, the assessment is made by putting the baby on the 
daylight or white light source. It is inaccurate after the phototherapy. This method divides 
the baby into 5 zones, in a cephalocaudal progression. According to the zone, the 
estimation of total serum bilirubin is increasing in trend towards caudal. However this 
method easily underestimates or overestimates the baby bilirubin level, especially in 
darkly pigmented babies (Demott K, et al; 2006) (Levene MI et al; 2008).  
Development of medical equipment, based on clinical needs has become possible thanks 
to the advancement of technology. The nightmare of taking blood from neonates for 
laboratory investigations has been a main driver for the development of alternative 
devices allowing non-invasive monitoring. It started with the transcutaneous bilirubin 
meters which were measuring basically the colour of the skin. These devices tend to be 
highly dependent on skin color and on accumulation of bilirubin in the skin, which is 
heavily affected by phototherapy.  
Clinical assessment of jaundice begins with visual assessment as the least invasive 
monitoring (Michael Kaplan et al; 2008). Then non-invasive devices can be used but the 
device must be reliable so that there is no under treatment or over treatment of neonatal 
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jaundice occurs. It is also in important to have a device that can give the fast reading on 
jaundice so that decision can be made on time. 
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Figure 1: Schematic diagram of Kramer’s rule. Numbers 1-5 referring to the respective areas. 
1 
2 
4 
3 
5 
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5 
5 
5 
4 
4 
xx 
 
The gold standard for monitoring neonatal jaundice is the total serum bilirubin (TSB) 
level. Besides TSB, other investigations such as blood grouping with Coomb’s test, 
Rhesus grouping and full blood count are also included in the jaundice work up. In 
HUSM, TSB sample will then be processed in the laboratory by the colourimetric method 
using Architect C800 (since 2009) and Olympus AU680 (since 2013) machine. The 
lacking of TSB measurement is the waiting time is not guaranteed. The optimum timing 
for the result to be available is within 30 minutes. However, the process of sending the 
sample from ward to the laboratory itself required additional timing.     
The current practice requires the patients to go to the clinics for blood taking. The 
compliance to this is not always good. Some people may postpone the visit to the clinic 
and search for alternative methods. That is why there is a need for alternative ways to 
determine the severity of the neonatal jaundice. 
Neonates do experience pain. Thus blood taking procedure as in neonatal jaundice is 
associated with pain. However, it is a need to do the serum bilirubin in order to give 
appropriate treatment for the neonatal jaundice. The failure of detecting and monitoring 
of neonatal jaundice can lead to unwanted complications. Wrong justification of neonatal 
jaundice can lead to over-treatment and under-treatment of neonatal jaundice.    
 
1.5 New modalities in monitoring  
The new development in jaundice monitoring is the usage of cutaneous bilirubin 
meter. The transcutaneous bilirubin (TcB) meter gained the popularity after being 
introduced. Apart from non-invasive, this device can give immediate result which cut 
down the waiting time for TSB to be ready. Increasing evidence showed that newer 
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transcutaneous bilirubin measurement device accurately predict bilirubin levels 
without blood taking. The great advantage for this non-invasive device are less 
traumatized to the patient, reduce the risk of infection and potential cost saving as 
well (KA Jangaard et al; 2006). To balance between the non invasive method and 
appropriate management of neonatal jaundice, each new device needs evaluation.  
Despite having a good prospect on measurement, TcB is not yet acceptable as a gold 
standard. The device is acceptable as a screening tool mainly because the reading is 
affected after the phototherapy (Yamauchi Y, 1990). Several TcB devices will be 
described here, which are Bilicheck, Bilimed and JM-103. Earlier devices give the 
reading of measurement in index number which then be converted to the actual 
bilirubin unit. Newer device now can give the result in the actual value.  
Bilicheck is a device which used multiple wavelengths by spectral reflectance. It 
offers better measurement despite different in skin pigmentation by measuring the 
optical densities of bilirubin, melanin and hemoglobin in the skin. Prior to usage, it 
needs to be calibrated using Bilical. Bilicheck gives the reading of 5 average 
measurements. Bilicheck was tested in Hospital Universiti Sains Malaysia (HUSM) 
in 2006 and the result showed it was a reliable device (Zaidi et al, 2006). Bilimed is a 
product from Medick, S.A France. The placement of the probe is not directly to the 
skin, but 2cm apart. It produces single beam generated from 10 light emitting diodes. 
JM-103 is another device from Draeger Medical System. The measurement using 2 
wavelengths and dual optical path system. There was a study by Francesco R et al 
(2012) comparing those 3 TcB devices on a multiracial populations Francesco R, et 
al, 2012). It concluded that Bilicheck and JM-103 gave the same weightage of 
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reliability as a screening tool in neonatal jaundice. However the Bilimed is not 
suitable.  
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Figure 2: Bilicheck device 
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Figure 3: Bilimed device 
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Figure 4: JM-103 device 
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1.6 Bilispect 
Advancement in technology also leads to development of Bilispect device. This is a 
hand held device for TcB measurement. Bilispect goes beyond the skin (MBR 
Optical System, 2012). It measures the bilirubin in the skin and the blood. Therefore 
it can be used before, during or after phototherapy. That is why in this study, the 
measurement included before and after phototherapy. It also can be used regardless 
of race different because it is not affected by skin color. It is a handy device that 
gives TcB measurement within 20 seconds. The button sensor needs to be place on 
baby’s skin and the reading will be ready in seconds. Some of the projected light is 
absorbed by the various components of tissue and bilirubin, while some of it is 
reflected. 
Another waveguide transmits the light reflected as a result of the physical conditions 
back to the device. A spectrometer breaks the light down into its separate 
wavelengths and an electronic evaluation unit analyses it. The resulting data is then 
processed using an algorithm developed by MBR and the derived rate of total 
bilirubin value is the resulting total bilirubin on the display of the device. 
The device is powered by batteries. A main adapter is included. With fully charged 
batteries, measurement for five hours is possible.  
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Figure 5: Bilispect device 
 
bono • 
I MM 
-
-
xxviii 
 
1.7 Rationale of the study 
The emergence of advance technology in medicine needs further statistical 
evaluation. Thus the need to test the reliability of this transcutaneous bilirubin meter 
is very important. The transcutaneous device that was introduced before is affected 
by phototherapy, which leads to limited usage for in patients. Bilispect is proposed 
as it can be used before and after phototherapy. Therefore, it is very important to do 
this study for future benefits of the babies with neonatal jaundice. If it is reliable as 
compared to TSB, it can be the important device in each neonatal ward. Bilispect can 
reduce the workload of the staff mainly doctors and can minimize blood taking in 
babies. This will prevent the underestimation of jaundice severity which will lead to 
severe neurotoxicity complications, as well as overtreatment which warrant 
unnecessary investigations and treatment for the babies. 
 
1.8 Treatment And Complication 
Phototherapy remains the mainstay of treatment for neonatal jaundice (Malaysia 
CPG management of neonatal jaundice, 2014). Newborn will be categorized 
according to gestational age, chronological age and risk factors. Several types of 
phototherapy are available; these are fluorescent tube, Light Emitting Diode (LED), 
fibreoptic and halogen bulbs. Other contributed factors for the efficacy are the blue 
light range of the phototherapy, the distance from photo to the babies and usage of 
reflecting curtain (Djokomuljanto et al; 2006). Exchange transfusion (ET) comes into 
the picture when TSB exceed phototherapy level (Malaysia CPG management of 
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neonatal jaundice, 2014). ET can reduce the TSB up to 43% (Salaas AA, 2008). The 
most common method for ET is using the umbilical vein catheter (UVC).  
The most unwanted complication of neonatal jaundice is acute bilirubin 
encephalopathy or kernicterus. There was no local study on the incidence of 
kernicterus for comparison. In North America and Europe, the estimated incidence of 
kernicterus ranges from 0.4 to 2.7 cases per 100,000 live births among term and 
late preterm babies (Maisels MJ et al; 2012).  The exact value for TSB level and 
kernicterus occurrence is unknown (Weng YH, 2011). Long term sequels of bilirubin 
neurotoxicity are athetoid cerebral palsy, severe deafness and intellectual disability 
(Bhutani VK, 2011). 
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CHAPTER 2: OBJECTIVES 
 
2.1 General Objective 
To correlate the result of Bilispect in comparison with serum bilirubin in term 
newborn babies. 
 
2.2 Specific Objectives 
1. To correlate the result of Bilispect in comparison with serum bilirubin in term 
babies prior to phototherapy 
2. To correlate the result of Bilispect in comparison with serum bilirubin in term 
babies after starting photo therapy 
 
2.3 Research hypothesis 
1. Bilispect reading is similar to serum bilirubin in newborn babies prior to 
phototherapy 
2. The reading of Bilispect is not affected even after phototherapy 
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CHAPTER 3: METHODOLOGY 
 
3.1 STUDY DESIGN 
 
This study was a prospective cross sectional study. 
 
 
3.2 SETTING 
 
This study was carried out in Hospital Universiti Sains Malaysia (HUSM), a 
tertiary teaching hospital in Kelantan, the most northeastern state of 
Peninsular Malaysia. HUSM receives referrals from the whole Kelantan and 
also from the bordering districts of neighbouring states. During the study 
period, neonatal jaundice patients were admitted either to the neonatal 
intensive care unit (NICU) or to the special care nursery (SCN), depending 
on the condition of the baby and the severity of jaundice. 
 
3.3 SUBJECTS 
The study population was recruited from babies who were admitted to the 
NICU or to the special care nursery during the study period that fulfilled the 
following inclusion and exclusion criteria. 
 
3.4 INCLUSION CRITERIA 
The inclusion criteria were: 
1. Neonatal jaundice during  the first 7 days of life 
2. Delivery at term (completed 37 weeks of gestation) 
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3.5 EXCLUSION CRITERIA 
The exclusion criterion was: 
1. Terminally ill babies (conservative management and not for any blood 
taking) 
 
3.6 DATA COLLECTION 
The main data collected for this study consisted of 59 serum bilirubin 
readings in jaundiced babies fulfilling the inclusion criteria pre-
phototherapy and another 59 post phototherapy.  Sampling of subjects and 
data was based on the convenience of the main investigator since there was 
only one unit of Bilispect available. 
  
The pre-phototherapy blood samples were collected according to the ward 
protocol where all babies admitted for jaundice, or admitted for other 
reasons but detected clinically to have jaundice, were subjected to blood 
taking for serum bilirubin, blood group with direct Coombs test and full 
blood count with reticulocytes. The sample was obtained via venous 
puncture. The reading of Bilispect was taken immediately after the blood 
taking. If the baby was found to have bilirubin levels below phototherapy, 
no further data were collected. 
The post phototherapy blood samples were collected during blood taking, 
four hours after start phototherapy or on the next morning, depending on the 
severity of jaundice and the baby’s condition.  This next blood taking was 
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also followed immediately by the Bilispect reading. Also for these post 
phototherapy data collection, the sampling of the subjects were done based 
on the convenience of the main investigator and whenever possible it was 
done for babies included in the study for pre phototherapy data collection 
too.  
 
Serum bilirubin was sent to the chemical pathology laboratory. The sample 
was not covered, but was sent to the laboratory following the protocol from 
the ward which tries to ensure speedy delivery to the laboratory. The time of 
sample collection and sample being processed was not recorded. The sample 
was then processed using the colorimetric method, using Architect C8000 
(Abbot, California) or Olympus AU680 (Beckman Coulter, California) and 
the results were obtained in the same units as Bilispect; µmol/L. After the 
measurements, the samples were destroyed as per laboratory standard 
protocol. The laboratory staff will do the calibration of the machine daily 
basis to ensure the result is reliable. 
 
The baseline data of the included subjects and the results of the blood 
investigations and the Bilispect reading were collected using a standard data 
collection sheet which is found in the Appendix 2 of this thesis. 
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3.7 BILISPECT READING 
Bilispect used in this study was a free loan device from the company (Pall-
Thai Medical Sdn Bhd). Only one unit was available. It was operated with 
the built in battery, which can last for 5 hours. It is a handy device, easily 
operated with button function. The command language is in English. Every 
time the Bilispect is turned on, it needs to be calibrated. After the 
calibration, the reading can be done and the result will be available after 10-
20 seconds. The results displayed as µmol/L. One reading is taken on every 
measurement.      
A total of 4 persons were involved as observer, which were the investigator 
and 3 other house-officers (HO). The investigator was trained by the 
distributor to use the device during a formal training session of about 30 
minutes. Subsequently the main investigator trained the 3 HO prior to 
starting of this study (for about 30 minutes). There was no inter-observer 
and intra-observer reliability test done.  
For sample collection, the site used was either at right or left forearm. The 
skin probe was cleaned using the alcohol wipe in between patients to 
minimize risk of infection. A picture of the Bilispect device during usage is 
shown in figure 6. 
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Figure 6: Picture of Bilispect usage 
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3.8 Sample size 
The sample size of the study was calculated using the Intra Class 
Correlation (ICC) from the website of Biostastic Unit, USM 
(http://www.medic.usm.my/biostat/images/files/Sample_size_calculation_v
1_7.xls). ICC was used based on the objectives of this study. Sample size 
was not required for general objective. For the specific objectives (1) and 
(2), the sample size calculation is using the intra Class Correlation (ICC) 
software as follows: 
 
Sample size calculation – Intra Class Correlation 
Observation/Subject (n) 2 
α  0.050 
Power (1-β) 0.800 
Acceptable reliability (p0) 0.8 
Expected  reliability (p1) 0.9 
Drop-out 20% 
   
Sample size 46 
Corrected sample size 58 
 
Table 2: Sample size calculation 
 
As this study was compared the two methods, subject number was put as 2.  
α is type 1 error. 
The power of the study was 80% with 20% drop out rate.   
Corrected calculation: (0.2 x 46) + 46=55.7 
For the purpose of this study, all newborns fulfilled the inclusion criteria were 
enrolled in the study during the study period.  
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3.9 Ethical issues 
 
All parents of the babies involved in this study gave their written informed 
consent for their babies to be included in this study. The study was 
approved by The Research Ethical Committee of School of Medical 
Sciences (PPSP), University Science of Malaysia on 1ST April 2015  
(Ref: USM/JEPeM/15020065). The consent form attached in Appendix 2. 
 
 
 
3.10  Statistical analysis 
 
Collected data were processed and analyzed using IBM SPSS 22. The 
demographic data were presented in the table as numbers and percentage with 
mean (SD) according to data distribution.  
The mean and difference value of pre-phototherapy group and post-phototherapy 
group were analyzed using the descriptive analysis. Based on the mean and 
difference value, the Bland Altman plot were derived. The statistical significant is 
defined as percentage of agreement. The upper and lower median line for the 
Bland Altman plot used the formula of 
(https://www.medcalc.org/manual/blandaltman.php): 
Mean +/- 1.96 x SD  
The degree of agreement between serum bilirubin and Bilispect was derived from: 
100 - (Number of outliers/ number of total subject x 100) 
